Viracta Therapeutics, Inc.
VIRXDelisted Jul 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061027
Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Viracta Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 41 | 42 | +1 |
| Shares | 9.97M | 9.69M | −274.1K (−2.7%) |
| Value | $14.1M | $10.1M | −$3.97M (−28.3%) |
New holders (8)
Institutions that held Viracta Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 12,084 | $12.6K | 0.00% |
| Simplex Trading, LLC | 1,142 | $1.00K | 0.00% |
| Indiana Trust & Investment Management CO | 200 | $208 | 0.00% |
| UBS Group AG | 65 | $68 | 0.00% |
| GWM Advisors LLC | 14 | $15 | 0.00% |
| Private Ocean, LLC | 3 | $3 | 0.00% |
| Qube Research & Technologies Ltd | 2 | $2 | 0.00% |
| NBC Securities, Inc. | 700 | $0 | 0.00% |
Sold out (7)
Institutions that held Viracta Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jane Street Group, LLC | 41,854 | $59.0K |
| HRT Financial LP | 17,291 | $24.0K |
| Susquehanna International Group, LLP | 16,793 | $23.7K |
| Two Sigma Advisers, LP | 12,719 | $17.9K |
| Advisor Group Holdings, Inc. | 4,564 | $6.12K |
| Group One Trading, L.P. | 100 | $141 |
| FMR LLC | 8 | $12 |